-
The first day of "national talk": respiratory, anti-infection and other drug competition!
Time of Update: 2023-02-02
According to this year's medical insurance negotiation rules, for high-priced drugs to be included in the formal review, the National Health Insurance Administration said that this year, some more expensive drugs passed the preliminary formal review, only indicating that the drug meets the declaration conditions and has been qualified to enter the next link.
-
Paxlovid failed to be included in the medical insurance catalogue The other two new crown drugs were successfully negotiated
Time of Update: 2023-02-02
According to China's National Medical Security Administration, the negotiation of the 2022 national medical insurance drug catalogue officially ended on January 8, and the combination packaging of ne
-
National Health Insurance Administration: Guard the bottom line of preventing large-scale return to poverty due to illness
Time of Update: 2023-02-02
In order to do a good job in the normalization of monitoring and assistance for low-income rural populations, further improve the accuracy and timeliness of assistance, and effectively prevent and re
-
The "2022 White Paper on Healthy Hair Consumption of Urban People" was released, and more than 50% of the post-00s have hair loss problems
Time of Update: 2023-02-02
In recent years, the health awareness of the Chinese people has been continuously improved, and people have paid more attention to regulating their own health conditions, among which hair health has
-
In order to solve the development dilemma, the split and merger of pharmaceutical companies will become a "regular operation"
Time of Update: 2023-02-01
Not long ago, on December 19, 2022, Luye Pharmaceutical announced that Boan Biotech, a holding subsidiary and innovative biopharmaceutical company, entered the IPO stage and will be listed on the Hong Kong Stock Exchange.
-
The number of lung CT examinations has surged, and related concept stocks have attracted the attention of the industry
Time of Update: 2023-02-01
It is reported that in order to reduce the pressure on major hospitals, United Imaging Medical is also accelerating the promotion of Tianyan CT into community hospitals.
-
In 2023, the pharmaceutical industry will continue to set off a wave of cooperation!
Time of Update: 2023-02-01
It is understood that before that, Biocytogen provided Hansen Pharmaceutical with candidate fully human antibody molecules for its selected targets generated by the "Thousand Mouse AntibodiesTM" project, and Hansen Pharmaceutical exercised the right to choose after completing the evaluation of candidate antibody molecules to reach the license agreement.
-
On January 11, 17 pharmaceutical stocks in the two cities had block trading, and 3 of them had a turnover of more than 300 million yuan
Time of Update: 2023-02-01
In terms of average transaction price, the average transaction price of three stocks of Kaileying, BeiGene and Tigermed Pharma was more than 100 yuan, and the average transaction price of WuXi AppTec, Zhaoyan New Drug, Yifeng Pharmacy and Yunnan Baiyao exceeded 50 yuan.
-
The field of APIs has "turned over", and the performance of a large number of enterprises has increased significantly
Time of Update: 2023-02-01
【Pharmaceutical Network Market Analysis】 Recently, with the gradual liberalization of epidemic prevention and control, the pharmaceutical market has attracted much attention from the capital market, e
-
The pharmaceutical and biological industry rose 0.65% on January 9, and 1 individual stock rose to the limit
Time of Update: 2023-02-01
From the perspective of capital flow on January 9, the net outflow of main funds in the pharmaceutical and biological industry on the 9th was 1.
From the perspective of capital flow on January 9, the net outflow of main funds in the pharmaceutical and biological industry on the 9th was 1.
-
The price of Chinese medicinal materials has skyrocketed, and the cost of raw materials of Sunflower Pharmaceutical has increased!
Time of Update: 2023-02-01
Fourth, children's lung heat cough and asthma oral liquid raw material market comment Ephedra, the origin of Inner Mongolia has recently taken normal goods, the production area is about to end processing, the New Year is approaching, merchants have also taken holidays for the New Year, and the logistics of the origin have been suspended.
-
The biological products sector was active, and 5 stocks such as Bailey Tianheng-U closed up more than 10% on January 13
Time of Update: 2023-02-01
According to the data, Baili Tianheng is a pharmaceutical stock listed on the Science and Technology Innovation Board on January 6, 2023, and the pharmaceutical company has a full range of drug research and development production capacity, including small molecule chemical drugs, large molecule biological drugs and antibody conjugate drugs (ADC drugs).
-
How to improve the capacity of rural new crown severe disease treatment? Official response
Time of Update: 2023-02-01
3% from the peak 。 Jiao Yahui said that the detection rate of new crown positive infections in fever clinics also continued to decline, with a peak detection rate of 33.
-
The traditional Chinese medicine sector will continue to strengthen, and the long-term development in these areas is also promising
Time of Update: 2023-02-01
In recent years, while continuously encouraging the innovation of traditional Chinese medicines and accelerating the review and approval, domestic policies are also further focusing on the quality, cl
-
The overall cost of implanting a tooth is expected to be halved and implemented in late March at the earliest
Time of Update: 2023-02-01
"Planting full teeth is equivalent to buying a suite in the county", "One tooth is equal to a BMW". . . For a long time, the high cost of dental implants has discouraged many people who are suffering
-
Innovative drugs and traditional Chinese medicine concept stocks continue to strengthen, and many stocks rose to the limit on January 16!
Time of Update: 2023-02-01
On the news, Hengrui Pharmaceutical issued an announcement on the evening of January 15 that the company recently received the "Drug Registration Certificate" of cyclophosphamide capsules approved and issued by the State Food and Drug Administration.
-
Following montmorillonite and norfloxacin, another drug has joined the wave of hoarding?
Time of Update: 2023-02-01
According to public information, King Dawei is the leading manufacturer of coenzyme Q10 raw materials in China, and the company's production capacity of coenzyme Q10 reached 600 tons at the end of 2021.
-
Centralized procurement of oral implant systems yields the results of the proposed selection and reduces the average price by 55%
Time of Update: 2023-02-01
In the next step, the medical insurance department will make preparations before the implementation of the results of centralized procurement, and in the near future, it will also carry out bidding and listing of crown consumables used in the process of dental implants, and simultaneously implement the whole process of price regulation of oral implant medical services, so that the three main cost components of dental implant services will be reduced simultaneously.
-
Oral implant centralized procurement and opening bidding, volume in exchange for price to "knock down" the price of dental implants
Time of Update: 2023-02-01
js?cdnversion='+~(-new Date()/36e5)];The Provincial Alliance for Oral Implant Systems opened bids in Chengdu on the 11th, which is the first attempt to expand the centralized procurement of high-value consumables from the medical insurance field to the non-medical insurance field.
-
Ministry of Civil Affairs: Establish a direct hotline between urban and rural communities and the pharmacies of medical institutions
Time of Update: 2023-02-01
js?cdnversion='+~(-new Date()/36e5)];On January 11, the joint prevention and control mechanism of the State Council held a press conference to introduce the relevant situation of epidemic prevention and control in key institutions and key places.
![9-[3-Chloro-5-(phenanthren-9-yl)phenyl]phenanthrene / 1369431-34-4](https://file.echemi.com/fileManage/upload/goodpicture/20241028/9-3-chloro-5-phenanthren-9-ylphenylphenanthrene-1369431-34-4_b20241028151130118.jpg)
